![Gary Sender](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Gary Sender
Directeur/Bestuurslid bij
SCHRÖDINGER, INC.
Vermogen: 397 242 $ op 31-07-2026
Profiel
Gary L.
Sender is currently an Independent Director at Schrödinger, Inc. since 2019, Independent Director at iBio, Inc. since 2020, Director at Elucida Oncology, Inc. since 2021, Independent Director at Harmony Biosciences Holdings, Inc. since 2020, Director at Harmony Biosciences LLC, Director at Gennao Bio, Inc. since 2021, Director at Apnimed, Inc. since 2024, and President of Sender Consulting LLC.
Former roles include Senior Vice President-Finance at Shire Plc from 2009 to 2015, CFO and Vice President-Finance & Administration at Tengion, Inc. from 2004 to 2009, Chief Financial Officer at Nabriva Therapeutics GmbH from 2016 to 2017, Chief Financial Officer & Executive Vice President at Synergy Pharmaceuticals LLC from 2015 to 2016, Chief Financial Officer at Nabriva Therapeutics Plc from 2016 to 2021, and Head-Investor Relations & Treasury at Merck & Co. Education includes an MBA from Carnegie Mellon University and undergraduate studies at Boston University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
SCHRODINGER, INC. 0,04% | 22-06-2026 | 25.388 ( 0,04% ) | 384 374 $ | 31-07-2026 |
IBIO, INC. 0,03% | 20-11-2025 | 9.191 ( 0,03% ) | 12 867 $ | 31-07-2026 |
APNIMED, INC. -.--% | 03-08-2026 | 0 ( -.--% ) | - $ | 31-07-2026 |
| 14-05-2026 | 0 ( -.--% ) | - $ | 31-07-2026 |
Actieve functies van Gary Sender
| Bedrijven | Functie | Begin |
|---|---|---|
| SCHRÖDINGER, INC. | Directeur/Bestuurslid | 01-07-2019 |
| IBIO, INC. | Directeur/Bestuurslid | 14-10-2020 |
| HARMONY BIOSCIENCES HOLDINGS, INC. | Directeur/Bestuurslid | 01-08-2020 |
| APNIMED, INC. | Directeur/Bestuurslid | 01-10-2024 |
Elucida Oncology, Inc.
 Elucida Oncology, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which focuses on clinical research and development | Directeur/Bestuurslid | 29-04-2021 |
Harmony Biosciences LLC
 Harmony Biosciences LLC Pharmaceuticals: MajorHealth Technology Develops and commercializes therapies for people living with rare neurological disorders | Directeur/Bestuurslid | - |
Gennao Bio, Inc.
 Gennao Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops targeted nucleic acid therapeutics to cure muscle diseases | Directeur/Bestuurslid | 08-09-2021 |
Eerdere bekende functies van Gary Sender
| Bedrijven | Functie | Einde |
|---|---|---|
| NABRIVA THERAPEUTICS PLC | Financieel Directeur/CFO | 12-03-2021 |
Nabriva Therapeutics GmbH
 Nabriva Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Provides pharmaceutical research and development services | Financieel Directeur/CFO | 23-06-2017 |
| ░░░░░░░ ░░░░░░░░░░░░░░░ ░░░ | ░░░░░░░░░░ ░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░ ░░░░░ | ░░░░░░░░░░ ░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░ | ░░░░░░░░░░ ░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Opleiding van Gary Sender
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
58
Eerstegraads connecties
15
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 15 |
|---|---|
Carnegie Mellon University
 Carnegie Mellon University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Shire Plc /Old/
 Shire Plc /Old/ Miscellaneous Commercial ServicesCommercial Services Develops, manufactures and markets pharmaceuticals | Commercial Services |
Tengion, Inc.
 Tengion, Inc. BiotechnologyHealth Technology Develops new human organs and tissues | Health Technology |
Boston University
 Boston University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Schrödinger, Inc.
 Schrödinger, Inc. Packaged SoftwareTechnology Services Develops physics-based software platform which enables discovery of novel molecules for drug development and materials applications | Technology Services |
Nabriva Therapeutics GmbH
Nabriva Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Provides pharmaceutical research and development services | Health Technology |
Synergy Pharmaceuticals LLC
 Synergy Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops drugs to treat gastrointestinal disorders and diseases | Health Technology |
iBio, Inc.
 iBio, Inc. Pharmaceuticals: OtherHealth Technology Engages in the development and commercialization of vaccines and therapeutic proteins | Health Technology |
Nabriva Therapeutics Plc
 Nabriva Therapeutics Plc Pharmaceuticals: MajorHealth Technology Engages in the research, development, and commercialization of novel anti-infective agents | Health Technology |
Elucida Oncology, Inc.
Elucida Oncology, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which focuses on clinical research and development | Health Technology |
Harmony Biosciences Holdings, Inc.
 Harmony Biosciences Holdings, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapies for patients living with rare neurological disorders | Health Technology |
Harmony Biosciences LLC
Harmony Biosciences LLC Pharmaceuticals: MajorHealth Technology Develops and commercializes therapies for people living with rare neurological disorders | Health Technology |
Apnimed, Inc.
 Apnimed, Inc. BiotechnologyHealth Technology Engages in developing and commercializing of proprietary therapeutics for sleep apnea & breathing diseases | Health Technology |
Merck & Co.
 Merck & Co. Real Estate DevelopmentFinance Operators of Nonresidential Buildings | Finance |
Gennao Bio, Inc.
Gennao Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops targeted nucleic acid therapeutics to cure muscle diseases | Health Technology |
